OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Safety and Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in Individuals ≥12 Years Old: A Phase 2/3 Trial
Juleen Gayed, Oyeniyi Diya, Francine S. Lowry, et al.
(2024)
Open Access | Times Cited: 9
Juleen Gayed, Oyeniyi Diya, Francine S. Lowry, et al.
(2024)
Open Access | Times Cited: 9
Showing 9 citing articles:
Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detection Techniques, and Post-Pandemic Treatment Strategies
Y.-C. Chung, Ching-Yin Lam, Pak-Hei Tan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8155-8155
Open Access | Times Cited: 6
Y.-C. Chung, Ching-Yin Lam, Pak-Hei Tan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8155-8155
Open Access | Times Cited: 6
Safety and Immunogenicity of Omicron Protein Vaccines in mRNA-Vaccinated Adolescents: A Phase 3, Randomised Trial
Chijioke Bennett, Gordon Chau, Elizabeth Clayton, et al.
Journal of Infection (2025), pp. 106428-106428
Open Access
Chijioke Bennett, Gordon Chau, Elizabeth Clayton, et al.
Journal of Infection (2025), pp. 106428-106428
Open Access
Safety comparison between Pfizer BNT162b2, Moderna mRNA-1273, and AstraZeneca AZD1222 in a Nationwide prospective cohort survey at the beginning of the severe acute respiratory syndrome coronavirus 2 vaccination in Japan
Suminobu Ito, Nao Tsuchida, Susumu Kusunoki, et al.
Vaccine (2025) Vol. 49, pp. 126754-126754
Open Access
Suminobu Ito, Nao Tsuchida, Susumu Kusunoki, et al.
Vaccine (2025) Vol. 49, pp. 126754-126754
Open Access
Virological Traits of the SARS-CoV-2 BA.2.87.1 Lineage
Lu Zhang, Alexandra Dopfer‐Jablonka, Inga Nehlmeier, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 487-487
Open Access | Times Cited: 3
Lu Zhang, Alexandra Dopfer‐Jablonka, Inga Nehlmeier, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 487-487
Open Access | Times Cited: 3
Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine against XBB.1.5, BA.2.86, and JN.1 Sublineages: A Phase 2/3 Trial
Juleen Gayed, Vishva Bangad, Xia Xu, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 734-734
Open Access | Times Cited: 3
Juleen Gayed, Vishva Bangad, Xia Xu, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 734-734
Open Access | Times Cited: 3
Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in People Living with HIV (PLWH)
Maxim Cherneha, Isabel Zydek, Peer Braß, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 785-785
Open Access | Times Cited: 1
Maxim Cherneha, Isabel Zydek, Peer Braß, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 785-785
Open Access | Times Cited: 1
Navigating the Evolving Landscape of COVID-19: Strategies to Increase Vaccine Confidence and Improve Vaccination Rates in the United States
James A. Mansi, Heather R. Hensler, Rachel Dawson, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1072-1072
Open Access | Times Cited: 1
James A. Mansi, Heather R. Hensler, Rachel Dawson, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1072-1072
Open Access | Times Cited: 1
Risk of COVID-19 in Children throughout the Pandemic and the Role of Vaccination: A Narrative Review
David J. Weber, Kanecia O. Zimmerman, Sara Y. Tartof, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 989-989
Open Access
David J. Weber, Kanecia O. Zimmerman, Sara Y. Tartof, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 989-989
Open Access
